| Identification | Back Directory | [Name]
4-Oxazolidinecarboxamide, 5-methyl-N-[(1S)-2-[(2R)-2-methyl-1-pyrrolidinyl]-2-oxo-1-(4-thiazolylmethyl)ethyl]-2-oxo-, (4S,5S)- | [CAS]
204386-76-5 | [Synonyms]
S0373 S-0373 S 0373 Rovatirelin 4-Oxazolidinecarboxamide, 5-methyl-N-[(1S)-2-[(2R)-2-methyl-1-pyrrolidinyl]-2-oxo-1-(4-thiazolylmethyl)ethyl]-2-oxo-, (4S,5S)- | [Molecular Formula]
C16H22N4O4S | [MDL Number]
MFCD33404550 | [MOL File]
204386-76-5.mol | [Molecular Weight]
366.44 |
| Hazard Information | Back Directory | [Uses]
Rovatirelin is an orally active thyrotropin-releasing hormone (TRH) analog. Rovatirelin binds to the human TRH receptor with a Ki value of 702 nM. Rovatirelin can be used to study spinocerebellar degeneration (SCD) [1]. | [References]
[1] Ijiro T, et al. Effect of rovatirelin, a novel thyrotropin-releasing hormone analog, on the central noradrenergic system. Eur J Pharmacol. 2015 Aug 15;761:413-22. DOI:10.1016/j.ejphar.2015.05.047 |
|
|